<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Nature Network - Notices from Life Science Business Development</title>
    <link>http://network.nature.com/group/G31931CD1</link>
    <description>Latest group notices from the administrators of Life Science Business Development</description>
    <language>en-us</language>
    <ttl>40</ttl>
    <item>
      <title>Business Scenario 1: </title>
      <pubDate>Tue, 20 Mar 2007 08:13:58 -0000</pubDate>
      <link>http://network.nature.com/groups/G31931CD1/notice/2007/03/20/business-scenario-1</link>
      <guid>http://network.nature.com/groups/G31931CD1/notice/2007/03/20/business-scenario-1</guid>
      <description>
        <![CDATA[<p>A small Life-Science firm specializes in testing of food and water for suspected germs. According to very strict German hygiene laws, all foods and beverages production must be monitored by microbiological testing routines.<br />Until now, the firm uses techniques employing spectroscopy. Currently the firms proprietary testing system is sold under an own brand name, but so far large-scale sales have not kicked in yet.<br />In a partnership with a research institute nearby, the firm tries to license an advanced technology plattform, using electrical microarrays (vulgo Biochips).</p>


	<p>In the same way the company is willing to enter new markets besides the highly competitive food &#38; beverage industry. Therefore it seeks to contact large chemical companies residing in the region.</p>


	<p>Q:<br />How can my company exploit this situation in order to shape a business development case, producing revenue for us??</p>]]>
      </description>
    </item>
  </channel>
</rss>
